The diastolic pressure difference (DPD) is recommended to differentiate between isolated postcapillary and combined pre-/ postcapillary pulmonary hypertension (Cpc-PH) in left heart disease (PH-LHD). However, in usual practice, negative DPD values are commonly calculated, potentially related to the use of mean pulmonary artery wedge pressure (PAWP). We used the ECG to gate late-diastolic PAWP measurements. We examined the method's impact on calculated DPD, PH-LHD subclassification, hemodynamic profiles, and mortality.
A mong patients with heart failure with reduced ejection fraction (HFrEF), the presence of pulmonary hypertension (PH) portends a worse prognosis compared with those without PH. By definition, the majority of patients with HFrEF who demonstrate PH are classified clinically and hemodynamically as World Health Organization Group 2 or PH caused by left heart disease (PH-LHD). Furthermore, the severity of PH is associated with increased postoperative mortality in the event of heart transplantation. 1 As such, hemodynamic assessment by right heart catheterization is a prerequisite in the assessment heart transplant candidacy, and the presence of PH affects decision making around the listing process. Patients with HFrEF and PH are further divided based on whether PH is isolated postcapillary PH (Ipc-PH) or combined pre-and postcapillary PH (Cpc-PH). In both circumstances, adverse outcomes are related, in part, to afterload stress to the right ventricle (RV). The presence of Cpc-PH implies pulmonary vascular dysfunction that further imposes the risk of persistent PH post-transplant and detrimental afterload stress to the unconditioned donor RV.
In the setting of PH-LHD, a diastolic pressure difference (DPD) of ≥7 mm Hg has been proposed to differentiate Ipc-PH and Cpc-PH. 2, 3 The physiological rationale for this is based on the expectation that by late diastole, the pressure gradient or difference between the pulmonary artery (PA) and left atrium should be minimal. 4 In usual practice, the DPD is calculated as (diastolic PA pressure [dPAP] minus mean PA wedge pressure [PAWP] ). dPAP is measured in late diastole, but the practice of PAWP measurement is variable. The mean PAWP >2 to 3 respiratory cycles 5 and the end-expiratory mean 6 have been suggested, whereas some centers use the pre-C wave or average of the A wave to estimate left ventricular end-diastolic pressure. The use of these PAWP measurements may overestimate left atrial pressure in late diastole at the end of diastasis, particularly when using the mean PAWP in the presence of severe mitral regurgitation and large systolic V waves. 7 As such, the DPD may be underestimated in usual practice, consistent with the observation that negative DPD values are commonly calculated in patients with HFrEF. 8 This may also contribute to the variability of results with respect to the prognostic value of the DPD. 8, 9 In this study, we developed methodology to measure the PAWP in late diastole using the QRS complex of the ECG recording to approximate the DPD in late diastole (QRS-gated DPD). We then tested the hypothesis that the proportion of patients classified as Ipc-PH and Cpc-PH would be significantly altered by the QRS-gated DPD method compared with the DPD calculated as in usual practice, in a cohort of patients with HFrEF undergoing right heart catheterization for evaluation of transplant candidacy. Furthermore, we hypothesized that the reclassified Cpc-PH group would demonstrate a hemodynamic profile consistent with increased RV afterload. Finally, 1-year follow-up of the cohort was performed to examine whether the QRS-gated DPD reclassification of PH was related to mortality.
METHODS

Catheterization Cohort
From April 2011 to March 2016, consecutive ambulatory patients aged >18 years with an EF <40%, undergoing right heart catheterization to evaluate candidacy for heart transplantation at Mount Sinai Hospital/University Health Network were prospectively enrolled into a clinical and hemodynamic registry. Right heart catheterization was arranged only after optimization of guideline-directed medical therapy was achieved in the clinical or hospital setting. Data on demographics, relevant cardiovascular and comorbid conditions, hospitalizations and medications, and biochemical and imaging tests were extracted prospectively in standardized case
WHAT IS NEW?
• The diastolic pressure difference (DPD; diastolic pulmonary artery pressure-pulmonary artery wedge pressure) has been used to characterize the resistance across the pulmonary circulation in the setting of left heart disease.
• However, the use of the mean PCW may result in a negative DPD values and confusion as to the contributions of pre-and postcapillary pulmonary hypertension to the hemodynamic picture.
• A novel approach, using QRS gating, to calculate the DPD across the pulmonary circulation was developed and tested in a cohort of advanced heart failure patients.
• Using this methodology, there were a larger proportion of patients classified as having mixed pulmonary hypertension (eg, both pre-and postcapillary pulmonary hypertension).
WHAT ARE THE CLINICAL IMPLICATIONS?
• A substantial proportion of patients with advanced heart failure have concomitant pulmonary hypertension.
• The presence of mixed pulmonary hypertension leads to worse outcomes after cardiac transplantation, and it can thus affect transplant candidacy.
• Our data suggest that the current practice to calculate the DPD using mean wedge pressure in patients with heart failure may systematically underestimate the role that precapillary mechanisms play in mediating pulmonary hypertension.
• Our new method of calculating the DPD, using QRS gating, may improve the clinician's ability to recognize the presence and risk of precapillary pulmonary hypertension.
report intake forms at the time of catheterization. Data were included if right heart catheterization was performed for the first time in the evaluation process. Patients with acute decompensation, receiving inotropic support, mechanical circulatory support, or diagnosed with acute myocarditis were excluded. Cases were also excluded if an acute coronary syndrome or revascularization occurred within 7 days before the study. Severe valvular heart disease and complex congenital heart disease were further exclusion criteria. All subjects provided written, informed consent to participate in the registry. This project was approved by both the Mount Sinai Hospital and University Health Network research ethics boards.
Standard Practices for Right Heart Catheterization and Hemodynamic Analysis
All procedures were performed at the Mount Sinai Hospital Cardiac Catheterization Research Laboratory by heart failure specialists with standard operating procedures for acquisition of hemodynamic data. Oral medications were withheld on the morning of the study. Patients presented after fasting and were minimally sedated. A balloon-floatation PA catheter was introduced, and the manometer was zeroed at the level of the midaxillary line. 5 Under fluoroscopic guidance, the catheter was positioned sequentially in the mid-right atrium, RV, and then a main PA branch. In the PA, the balloon was inflated, a blood sample was withdrawn to confirm arterial saturation, and the PAWP was acquired. In each position, waveforms were inspected for artifacts and the catheter was repositioned if atrial or ventricular extrasystoles occurred. Mixed venous blood was sampled for oximetry, and Fick cardiac output and stroke volume were determined and indexed to body surface area. Each pressure measurement (right atrium, RV, systolic PAP/dPAP/mean PA pressure [mPAP] , and mean PAWP) was acquired during briefly held end expiration, 6 ,10 using a commercial system (MacLab V.6.5; GE Healthcare). These automated digital measurements populate a summary hemodynamic report that becomes part of the patient record. In our laboratory, all raw pressure waveforms are recorded continuously (300 Hz) throughout each case and stored for offline analysis. Calculated variables include the transpulmonary gradient (mPAP-mean PAWP), pulmonary vascular resistance (transpulmonary gradient/cardiac output), and PA compliance (stroke volume/[systolic PA pressure-dPAP]). PA effective arterial elastance was calculated as (systolic PA pressure/stroke volume).
11
Development of the QRS-Gated DPD Calculation
A method of pressure sampling was developed to reflect the physiological basis of the DPD and that was objective and reproducible. In principle, the DPD represents the residual PA−left atrial pressure gradient in late diastole when PA Windkessel function and left atrial conduit function have completed. 4 In patients with HFrEF, systolic PAWP V waves may substantially augment the mean PAWP, 7 potentially overestimating late diastolic left atrial pressure and underestimating the DPD by extension. Accordingly, the onset of the QRS complex was selected as an objective time-point that corresponded to late diastole during the PAWP tracing.
The pressure on the PAWP tracing was then measured at this point ( Figure 1A and 1B). An expanded description and rationale for this method is presented in the Data Supplement.
Pressure Measurements for the QRSGated and Usual Practice DPD Calculation
Stored hemodynamic waveforms were analyzed offline by study personnel, blinded to patient characteristics. The PA and PAWP tracings were individually inspected, and intervals containing 8 to 10 cardiac cycles were selected. Automated measurements of systolic PA pressure/dPAP/mPAP and mean PAWP were then performed to replicate usual practice. For each cardiac cycle in the selected interval of the PAWP tracing, the peak V-wave pressure, and the pressure gated to the onset of the ECG QRS complex (QRS-gated PAWP), were measured manually beat-by-beat using a digital caliper and averaged over the 8 to 10 cardiac cycles. The usual practice DPD was calculated as (dPAP−mean PAWP), and the QRS-gated DPD was calculated as (dPAP−QRS-gated PAWP). Figure 1 illustrates the effect of using the mean PAWP or the QRS-gated PAWP on the calculation of DPD. The dPAP is plotted as a function of mean PAWP (C) and QRS-gated PAWP (D). The line of unity then represents a DPD=0 mm Hg. The dPAP and mean PAWP were linearly related (dPAP=0.8•mean PAWP+3; P<0.001) but crossed below the line of unity at a mean PAWP=18 mm Hg, suggesting that a negative value for usual practice DPD was increasingly likely when mean PAWP>18 mm Hg. The dPAP and QRS-gated PAWP were also linearly related (dPAP=1.0•QRS-gated PAWP+2; P<0.001), but did not intersect the line of unity. Accordingly, the difference between the QRS-gated DPD and the usual practice DPD was small when V-wave amplitude was low, but increased linearly as the V-wave increased (Data Supplement).
Hemodynamic Classifications
Hemodynamic classification was based on the following definitions: PH, mPAP≥25 mm Hg; pulmonary arterial hypertension, mPAP≥25 mm Hg and mean PAWP≤15 mm Hg; PH-LHD, mPAP≥25 mm Hg and mean PAWP>15 mm Hg; Ipc-PH, mPAP≥25 mm Hg, mean PAWP>15 mm Hg, and DPD<7 mm Hg; and Cpc-PH, mPAP≥25 mm Hg, mean PAWP>15 mm Hg, and DPD≥7 mm Hg. Patients with PH-LHD were then subclassified by the usual practice DPD and the QRS-gated DPD methods. Patients were classified in 4 different groups based on the hemodynamic profile: no PH, pulmonary arterial hypertension, Ipc-PH, and Cpc-PH.
Outcomes
To provide a description of clinical outcomes in the study cohort, death, cardiac transplantation, and left ventricular assist device implantation occurring within 1 year of followup were collected retrospectively from chart review.
Statistical Analysis
Statistical analyses were performed using SPSS Statistics V.20 (IBM). Normally distributed data are presented as mean±SD; non-normally distributed data are presented as median [interquartile range] as appropriate. Normality was assessed using the Kolmogorov-Smirnov test and examination of Q-Q plots. Continuous variables were compared between groups using 1-way ANOVA or the Kruskal-Wallis test, and unpaired comparisons were made using t tests or the Mann-Whitney U test as appropriate. Relationships between continuous variables were explored using linear regression. Categorical data were summarized as proportions, and comparisons between groups were made using χ 2 or Fisher exact test when appropriate. The frequency of clinical outcomes in the study cohort was described. We evaluated differences in mortality between the Ipc-PH and the Cpc-PH groups as classified by the QRSgated DPD method using the Kaplan-Meier method and the log-rank test. An α level of 0.05 was considered significant.
RESULTS
Patient Characteristics
One hundred forty-one patients with advanced HFrEF were included in this study; clinical and hemodynamic characteristics are presented in Table 1 . Medical therapy included loop diuretics (88%), β-adrenergic receptor blockers (85%), angiotensin system antagonists (83%), and aldosterone antagonists (71%). PH was present in 81 patients (57%) of this population, classified hemodynamically as PH-LHD in 72 patients (51%) compared with pulmonary arterial hypertension in 9 patients (6%). The remaining 60 patients (43%) of the cohort had no PH. Compared with patients with no PH, patients with PH-LHD demonstrated greater severity of hemodynamic derangement, including lower cardiac index and higher filling pressures.
Calculation of the QRS-gated DPD and the Usual Practice DPD
Among the entire cohort, the usual practice DPD was 0 mm Hg [interquartile range, −3 to 3 mm Hg], and 43% had a negative usual practice DPD value. The recalculated QRS-gated DPD was 2 mm Hg [interquartile range, −1 to 5 mm Hg], and the proportion of negative QRSgated DPD values decreased to 26% (P<0.001). 
Classification of PH-LHD by the QRSGated DPD Versus Usual Practice DPD
Seventy-two patients were classified as having PH-LHD. The median usual practice DPD was 0 mm Hg [interquartile range, −3 to 3 mm Hg], whereas the median QRSgated DPD was 3 mm Hg [interquartile range, −1 to 6 mm Hg]. The value of usual practice DPD was a negative integer in 50% of the PH-LHD group compared with 25% by the QRS-gated DPD method (P=0.003). Based on the usual practice DPD, only 6 patients (8%) were classified as Cpc-PH. However, based on the QRS-gated DPD, 17 (24%) patients were classified as Cpc-PH (P=0.002), after reclassifying 11 (15%) patients. Figure 2 illustrates individual paired usual practice DPD and QRS-gated DPD data, stratified based on a usual practice DPD ≥ or < 0 mm Hg, demonstrating the shift in the integer value of DPD and reclassification of 11 patients from Ipc-PH to Cpc-PH.
Indices of Right Ventricular Afterload in Cpc-PH and Ipc-PH
The clinical and hemodynamic profiles of patients with PH-LHD, stratified by subtype based on classification by the usual practice DPD and the QRS-gated DPD, are reported in Table 2 . Subjects were either classified as Ipc-PH by both methods (left), classified as Cpc-PH by both methods (right), or classified as Ipc-PH using the usual practice DPD but reclassified as Cpc-PH by the QRS-gated DPD (center). Arterial blood pressure and PAWP were not statistically significantly different in all 3 groups. The 6 patients classified as Cpc-PH by both methods demonstrated markedly elevated PA pressures and pulmonary vascular resistance compared with patients classified as Ipc-PH by both methods. Effective arterial elastance and pulmonary artery time constant were also higher, BMI indicates body mass index; CI, cardiac index; CRT-D, cardiac resynchronization therapy-defibrillator; DBP, systemic diastolic blood pressure; dPAP, diastolic pulmonary artery pressure; ICD, implantable cardioverter defibrillator; MAP, systemic mean arterial pressure; mPAP, mean pulmonary artery pressure; mPAWP, mean pulmonary artery wedge pressure; mRAP, mean right atrial pressure; NYHA, New York Heart Association functional class; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; PH-LHD, pulmonary hypertension-left heart disease; SBP, systemic systolic blood pressure; sPAP, systolic pulmonary artery pressure; S V O 2 , mixed venous oxygen saturation; and SVI, stroke volume index. whereas PA compliance was depressed. The 11 patients reclassified as Cpc-PH by the QRS-gated DPD method also demonstrated significantly elevated PA pressures although not as high as patients classified as Cpc-PH by both methods. Although pulmonary vascular resistance and PA compliance were not significantly different from Ipc-PH, the trend to higher pulmonary vascular resistance and lower compliance yielded an pulmonary artery time constant that was significantly different from the group classified as Ipc-PH by both methods and similar to the group classified as Cpc-PH by both methods.
Relationship Between DPD and Mortality
Follow-up data at 1 year were available from 138 of 141 patients (98%; Figure 3 ).
DISCUSSION
For patients with HFrEF, right heart catheterization is essential to assess the presence and severity of PH, particularly as part of the evaluation of transplant candidacy. Yet, interpretation of hemodynamic measurements to discriminate Ipc-PH from Cpc-PH remains challenging. 10,12,13 Naeije et al 4 suggested that the DPD is superior to the transpulmonary gradient as a diagnostic marker of pulmonary vascular dysfunction, and a DPD≥7 mm Hg is recommended to indicate Cpc-PH. 2 However, several observations in HFrEF suggest the need to further standardize the approach to quantifying the DPD. 7, 10, 14 Cohort studies of HFrEF or heart transplant recipients have demonstrated conflicting results on the relationships between DPD and clinical outcomes. 8, 9, [15] [16] [17] In this population, negative DPD values are also commonly observed, 8 which would not be expected based on the physiology of pulmonary flow patterns in diastole.
In healthy patients, the PA pressure decays during diastole, normally approaching an asymptote 0 to 3 mm Hg above left atrial pressure in the absence of pulmonary vascular dysfunction, 18, 19 forming the rationale for a DPD≥7 mm Hg to indicate Cpc-PH. 4 Generally, the mean PAWP reasonably approximates diastolic left atrial pressure, [19] [20] [21] even though the mean PAWP is a summary representation of both systolic (reservoir/V wave) and diastolic (conduit/Y-descent) events in the left atrium. However, in PH-LHD, the presence of large V waves arithmetically augments the mean PAWP, 22 overestimating left atrial pressure in late diastole. 21 It has been suggested that the effect of large V waves in HFrEF on the value of the mean PAWP 7,14 is inversely associated with calculated DPD values. 8, 15 This may give rise to observed negative values for DPD in some cases, but more concerning is the possibility of inappropriately classifying a subset of patients with possible Cpc-PH as Ipc-PH. 14 Accordingly, in this study, we analyzed the effect of different methods to measure hemodynamic values used to calculate the DPD in a cohort of patients with HFrEF being evaluated for cardiac transplantation. We confirmed that the presence of a large V wave influences the mean PAWP 15 such that it diverges from diastolic PAWP, particularly when mean PAWP exceeds 15 to 18 mm Hg (Data Supplement). In our cohort, the value of the mean PAWP then influenced the likelihood of calculating a negative DPD value when performed in usual practice. By considering the physiology of PA-left atrial interaction in diastole, a BMI indicates body mass index; CI, cardiac index; Cpc-PH, pre-/postcapillary pulmonary hypertension; CRT-D, cardiac resynchronization therapy-defibrillator; DBP, systemic diastolic blood pressure; DPD, diastolic pressure difference; dPAP, diastolic pulmonary artery pressure; Ea, effective pulmonary arterial elastance; ICD, implantable cardioverter defibrillator; Ipc-PH, isolated postcapillary pulmonary hypertension; MAP, systemic mean arterial pressure; mPAP, mean pulmonary artery pressure; mPAWP, mean pulmonary artery wedge pressure; mRAP, mean right atrial pressure; NYHA, New York Heart Association functional class; PAC, pulmonary arterial compliance; PVR, pulmonary vascular resistance; PH, pulmonary hypertension; PH-LHD, pulmonary hypertensionleft heart disease; QRS DPD, DPD calculated by the QRS-gated method; QRS-PAWP, pulmonary artery wedge pressure gated to the QRS-complex; RC, pulmonary artery time constant; RVSWI, right ventricular stroke work index; SBP, systemic systolic blood pressure; sPAP, systolic pulmonary artery pressure; S V O 2 , mixed venous oxygen saturation; SVI, stroke volume index; TPG, transpulmonary gradient; Usual DPD, DPD calculated by the usual practice; and V wave, pulmonary artery wedge pressure V wave. *P<0.05 vs Iso/Iso. †P<0.01 vs Iso/Iso.
time interval-guided approach 23 was used using the QRS complex to gate PAWP measurements within late diastole, to minimize the influence of systolic V waves. The temporal delay between the ECG and PAWP tracings because of electromechanical delay 24 and retrograde left atrial pressure propagation 25 is such that QRS-onset typically occurs late within the left atrial conduit phase tracing, just before the A wave. 26 As such, the QRS onset was used to objectively and reproducibly demarcate late diastole. The QRS-gated PAWP approach was feasible, and when used to calculate the DPD, reduced the frequency of negative values. Importantly, compared with the usual practice DPD, the QRS-gated DPD hemodynamically reclassified 15% of patients with PH-LHD considered to have Ipc-PH as having Cpc-PH.
The cohort characteristics were typical of patients with HFrEF being evaluated for transplantation, being relatively young with a higher proportion of men. 27 As we included only ambulatory, stable patients, just under half of the cohort did not exhibit PH. Using a threshold QRS-gated DPD≥7 mm Hg, all patients defined as Cpc-PH by usual practice remained classified as Cpc-PH, and an additional group of Ipc-PH were reclassified as Cpc-PH. Compared with Ipc-PH, we observed similar New York Heart Association functional class and left ventricular EF and elevated left ventricular filling pressures. Compared with Ipc-PH, the 11 reclassified Cpc-PH cases demonstrated higher PA pressures and a modest trend toward augmented resistive afterload, 28 consistent with the presence of pulmonary vascular dysfunction superimposed on the retrograde transmission of elevated left-sided filling pressures. 10 This observation suggests that the QRS-DPD method may be more sensitive to identifying adverse pulmonary vascular characteristics in the setting of PH-LHD, before the development of marked increases in RV afterload. In our cohort, the reclassified Cpc-PH cases were thus in addition to the 6 original cases of Cpc-PH that demonstrated markedly higher PA pressures, as well as substantially augmented determinants of resistive and pulsatile afterload. 29 The question of whether the DPD can, or should, 30, 31 predict clinical outcome in HFrEF remains controversial. Considerations include (1) whether an elevated DPD indicates pulmonary vascular dysfunction and (2) the extent to which pulmonary vascular dysfunction portends worse prognosis in PH-LHD. In our relatively small sample size, we did not observe a difference in mortality for patients classified as Cpc-PH compared with Ipc-PH. However, we observed some trends suggesting that clinical outcomes may be different in the Cpc-PH group; a higher proportion of patients in the Cpc-PH group died and a lower proportion received cardiac transplant. Notably, our observations raise the possibility that previous retrospective studies of the DPD may have assigned a subset of Cpc-PH patients to Ipc-PH groups, based on an underestimated DPD. The observed trend toward greater use of left ventricular assist devices in patients with PH-LHD is not unexpected, given their recommendation as a bridge to candidacy in patients with PH. 32 More broadly, PH-LHD prognosis is likely linked not only to the severity of pulmonary vascular dysfunction but also degree of impairment of RV function, the latter of which is not necessarily reflected by an elevated DPD alone.
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Limitations
There are limitations which merit discussion. Detailed beat-by-beat hemodynamic analysis may not be feasible in the clinical catheterization laboratory environment; however, the proposed method is relatively simple, which may make it more easily deployable. Furthermore, as the ECG is routinely used in algorithms for automated hemodynamic analysis, QRS-gated DPD measurements may be automated. We calculated a Death, n (%) 4 (7) 11 (15) 8 (15) 3 (18) LVAD, n (%) 6 (10) 17 (24) 13 (24) 4 (24) Transplant, n (%) 13 (22) 10 (14) 9 (16) 1 (6) Note that patients may have had >1 event in follow-up. LVAD indicates left ventricular assist device; PH, pulmonary hypertension; and PH-LHD, pulmonary hypertension-left heart disease. difference between nonsimultaneous measurements of PA pressure and PAWP as a surrogate for the diastolic transpulmonary pressure gradient; however, the risk associated with simultaneous direct measurement of left atrial pressure precludes its routine use. Fluidfilled catheters are susceptible to ringing artifact, which may affect measured pressures. However, patients were studied at quiet rest, and waveforms were examined for artifact and corrected during data acquisition. Although the ideal approach to account for respiratory changes in pulmonary tracings remains under debate, current recommendations suggest the analysis of waveforms during spontaneous breathing. 33 In this study, PAWP was recorded at end-expiration. However, as both dPAP and PAWP were recorded at end-expiration, they should be similarly influenced. As both DPD methods were applied to a single population, statistical comparison of end points between methods was not feasible.
Conclusions
The usual practice of calculating the DPD may result in systematic underestimation of the DPD in patients with advanced heart failure, because of the influence of the PAWP V wave on the mean PAWP. A simple method of calculating the DPD based on QRS-gated measurements of PAWP (the QRS-gated DPD) reduces the frequency of negative values, increases group-average DPD, and reclassifies a subset of patients with heart failure as Cpc-PH rather than Ipc-PH. This group is characterized by an adverse pulmonary hemodynamic profile. Additional work is required to determine whether a DPD threshold of ≥7 mm Hg remains optimal using this method and whether the threshold to detect the presence of pulmonary vascular dysfunction and to predict adverse outcome are one and the same.
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